Business
OMID Makes Strategic Investment Into Psychedelic Medicine
OMID Makes Strategic Investment Into Psychedelic Medicine.
About this update from Omid Holdings, Inc.
[{"type":"text","content":"\n\n\n\nOMID Makes Strategic Investment Into Psychedelic Medicine\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nOMID Makes Strategic Investment Into Psychedelic Medicine\nPR Newswire\nALPHA, N.J., Aug. 12, 2021\n\n\n\nALPHA, N.J., Aug. 12, 2021 /PRNewswire/ -- Today, OMID Holdings, Inc. (OTC Pink: OMID) is pleased to announce its initial investment to gain exposure to the legal psychedelic medicine industry. The investment made in the second quarter with KetaMD, which offers at-home medical ketamine treatments, marks the beginning of OMID's entry into another form of early-stage legal alternative medicines as the company seeks to further build its footprint in, and identity as, a life sciences company.\n\"Our cautiously optimistic initial investment in legal ketamine treatments represents our confidence in its many consumer benefits which aligns with our current cannabis-related business. We expect to continue to explore avenues to gain exposure to alternative medicines which represent an opportunity to broadly improve the health and wellness of consumers,\" stated Adam Frank, the Chairman and CEO of OMID Holdings, Inc.\nFor more information about KetaMD, please visit https://ketamd.com.\nAbout OMID Holdings, Inc.\nOMID Holdings, Inc. is a publicly-traded (OTC Pink: OMID) Florida corporation which focuses on developing and manufacturing various health and wellness products at its FDA-registered manufacturing facility in Phillipsburg, NJ. With a diverse portfolio of product types, OMID specializes in formulations which contain cannabis extracts as well as other herbal ingredients. The company objective is to provide quality, integrity, and value with notable consumer benefits derived from all of its finished consumer goods. \nFor more information about the company, please visit https://omidholdingsinc.com.\nSafe Harbor Act: Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial positio...